Genome Editing

CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT 5:15
CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT
John DiPersio • 21 Feb 2023
The safety and efficacy of UCART123v1.2 in R/R AML: results from AMELI-01 2:52
The safety and efficacy of UCART123v1.2 in R/R AML: results from AMELI-01
David Sallman • 11 Dec 2022
Targeting WT1 peptides for TCR-based AML therapy 2:04
Targeting WT1 peptides for TCR-based AML therapy
Chiara Bonini • 1 Apr 2022
TCR redirected T cells for cancer therapy 1:46
TCR redirected T cells for cancer therapy
Chiara Bonini • 1 Apr 2022
The use of CRISPR-Cas9 technology in the development of T cell therapies 0:55
The use of CRISPR-Cas9 technology in the development of T cell therapies
Alessio Nahmad • 31 Mar 2022
Overexpression of the LBTR gene to optimize T cell proliferation 1:54
Overexpression of the LBTR gene to optimize T cell proliferation
Mateusz Legut • 31 Mar 2022
Accelerating the identification of clinically relevant T cell therapies 2:17
Accelerating the identification of clinically relevant T cell therapies
Elvira D’Ippolito • 31 Mar 2022
Novel approaches in lymphocyte engineering 3:31
Novel approaches in lymphocyte engineering
Elvira D’Ippolito • 31 Mar 2022
Adapting cell therapies to solid tumors 2:57
Adapting cell therapies to solid tumors
Nina Bauer • 26 Jan 2022
The advantages and applications of CRISPR-Cas 9 1:47
The advantages and applications of CRISPR-Cas 9
Nina Bauer • 27 Jan 2022
Improving cell therapy manufacturing capabilities 1:11
Improving cell therapy manufacturing capabilities
Lavakumar Karyampudi • 27 Jan 2022
MOMENTUM: ARU-1801 in sickle cell disease 1:57
MOMENTUM: ARU-1801 in sickle cell disease
Will Chou • 26 Jan 2022
ARU-1801, a novel lentiviral gene therapy for SCD 2:26
ARU-1801, a novel lentiviral gene therapy for SCD
Will Chou • 27 Jan 2022
Looking forward to Advanced Therapies Week 2022 0:38
Looking forward to Advanced Therapies Week 2022
Janet Lynch Lambert • 26 Jan 2022
Non-viral gene delivery & gene editing: highlights from ESGCT 2:56
Non-viral gene delivery & gene editing: highlights from ESGCT
Ralf Schmid • 16 Nov 2021
CAR-Tregs for the treatment of systemic lupus erythematosus 3:06
CAR-Tregs for the treatment of systemic lupus erythematosus
Chiara Bonini • 22 Nov 2021
The content of VJRegenMed is intended for healthcare professionals